Seminars in Diagnostic Pathology
Volume 29, Issue 1 , Pages 19-30 , February 2012

Mastocytosis and related disorders

  • April Chiu, MD

      Affiliations

    • Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts
    • Corresponding Author InformationAddress reprint requests and correspondence: April Chiu, MD, Department of Pathology, Brigham and Women's Hospital, Amory 3-201, 75 Francis Street, Boston, MA 02115
  • ,
  • Attilio Orazi, MD, FRCPath

      Affiliations

    • Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York

  • Image Result

    Urticaria pigmentosa in skin biopsy of an adult with clusters of dermal mast cells.

    Urticaria pigmentosa in skin biopsy of an adult with clusters of dermal mast cells.

  • Image Result

    Systemic mastocytosis in bone marrow biopsy. The mast cell aggregate is sharply delineated and is present in the paratrabecular location (A). Within the mast cell lesion are many spindle-shape mast ce

    Systemic mastocytosis in bone marrow biopsy. The mast cell aggregate is sharply delineated and is present in the paratrabecular location (A). Within the mast cell lesion are many spindle-shape mast cells with admixed eosinophils, fibroblasts, and small lymphocytes (B).

  • Image Result
    The mast cells lesions typically show significant fibrosis with the presence of collagen, as shown by reticulin (A) and collagen (B) histochemical stains. In contrast with other fibrogenic myeloid neo

    The mast cells lesions typically show significant fibrosis with the presence of collagen, as shown by reticulin (A) and collagen (B) histochemical stains. In contrast with other fibrogenic myeloid neoplasms, the mast cell lesions are poor in vascularity as demonstrated by CD34 immunostaining (C). There is significant thickening (osteosclerosis) of the adjacent trabecular bone (D).

  • Image Result
    The neoplastic mast cells are often spindled shaped with asymmetric distribution of cytoplasmic metachromatic granules (A), although a variable number of round forms is usually also identified (B). Fr

    The neoplastic mast cells are often spindled shaped with asymmetric distribution of cytoplasmic metachromatic granules (A), although a variable number of round forms is usually also identified (B). Frequent atypical bi- or multilobated forms are seen in this case (C).

  • Image Result
    A case of primary myelofibrosis (cellular phase) with positive JAK-2 V617F point mutation marked by the presence of atypical, hyperlobated megakaryocytes forming clusters (A). The adjacent marrow show

    A case of primary myelofibrosis (cellular phase) with positive JAK-2 V617F point mutation marked by the presence of atypical, hyperlobated megakaryocytes forming clusters (A). The adjacent marrow shows an aggregate of mast cells (B) highlighted by mast cell tryptase immunostaining (C), indicating involvement by systemic mastocytosis with associated clonal hematological non mast cell lineage disease (SM-AHNMD/SM-PMF).

  • Image Result
    A case of mast cell leukemia showing a markedly increased number of atypical mast cells in the bone marrow aspirate smear (A) and peripheral blood involvement (B). The bone marrow biopsy shows diffuse

    A case of mast cell leukemia showing a markedly increased number of atypical mast cells in the bone marrow aspirate smear (A) and peripheral blood involvement (B). The bone marrow biopsy shows diffuse infiltration by the neoplastic mast cells (C) that are highlighted by mast cell tryptase immunostain (D).

  • Image Result
    Immunohistochemistry in a case of systemic mastocytosis. The mast cells are positive for mast cell tryptase (A) and CD117 (KIT) (B) and show aberrant expression for CD25 (C) and CD2 (D).

    Immunohistochemistry in a case of systemic mastocytosis. The mast cells are positive for mast cell tryptase (A) and CD117 (KIT) (B) and show aberrant expression for CD25 (C) and CD2 (D).

  • Image Result
    A case of FIP1L1–PDGFRA rearranged chronic eosinophilic leukemia. Note the increased number of mast cells (A), highlighted by mast cell tryptase (B).

    A case of FIP1L1–PDGFRA rearranged chronic eosinophilic leukemia. Note the increased number of mast cells (A), highlighted by mast cell tryptase (B).

 Competing interests: The authors declare no conflict of interest.

PII: S0740-2570(11)00087-6

doi: 10.1053/j.semdp.2011.06.002

Seminars in Diagnostic Pathology
Volume 29, Issue 1 , Pages 19-30 , February 2012